CH
抗体药类似物
Research Grade Opinercept
All
  • CatalogTD-HF879116
  • Clonality
  • Application Research Grade Biosimilar
  • SynonymsENIA11,TNFalphaR-Fc,TuNEX,CAS:2055118-96-0
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Opinercept


Catalog No. TD-HF879116
Species reactivity Human
Applications Research Grade Biosimilar
Isotype Fusion - [TNFRSF1B (tumor necrosis factor receptor (TNFR) superfamily member 1B, TNFBR, p75, CD120b)]2 - IGHG1 Fc (Fragment constant)
Expression system Mammalian Cells
Target TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P01375
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names ENIA11,TNFalphaR-Fc,TuNEX,CAS:2055118-96-0
Background Opinercept is a recombinant fusion protein comprising an TNFRSF1B fused to a human IgG1 Fc. Opinercept is a tumor necrosis factor-alpha (TNF-alpha) inhibitor. Opinercept can be used for the research of rheumatoid arthritis (RA).
Note For research use only. Not for use in clinical or therapeutic applications.